1. Stem Cell Therapy in Osteoarthritis: A Step Too Far?

   • Peter M. van der Kraan

   Current Opinion 09 March 2013 Pages: 175 - 180

2. The Outlook for Alemtuzumab in Multiple Sclerosis

   • Thomas Williams
   • Alasdair Coles
   • Laura Azzopardi

   Current Opinion 05 April 2013 Pages: 181 - 189

3. CD6 as a Therapeutic Target in Autoimmune Diseases: Successes and Challenges

   • Mafalda Pinto
   • Alexandre M. Carmo

   Leading Article 09 April 2013 Pages: 191 - 202

   

4. Development and Regulation of Biosimilars: Current Status and Future Challenges

   • Asterios S. Tsiftsoglou
   • Sol Ruiz
   • Christian K. Schneider

   Review Article 04 April 2013 Pages: 203 - 211

5. Regorafenib for Gastrointestinal Malignancies

   • Giuseppe Aprile
   • Marianna Macerelli
   • Francesco Giuliani

   Review Article 23 February 2013 Pages: 213 - 224

6. Belimumab Therapy in Systemic Lupus Erythematosus

   • Moncef Zouali
   • Eugene A. Uy

   Review Article 09 April 2013 Pages: 225 - 235

   

7. Gene Therapy for Fabry Disease: A Review of the Literature

   • Aritz Perez Ruiz de Garibay
   • María Ángeles Solinís
   • Alicia Rodríguez-Gascón

   Review Article 11 April 2013 Pages: 237 - 246

8. Adalimumab: A Review of Its Use in the Treatment of Patients with Ulcerative Colitis

   • Celeste B. Burness
   • Gillian M. Keating

   Adis Drug Evaluation 12 April 2013 Pages: 247 - 262

   

9. Multicomponent Meningococcal Serogroup B Vaccine (4CMenB; Bexsero^®): A Review of its Use in Primary and Booster Vaccination

   • Natalie J. Carter

   Adis Drug Evaluation 11 April 2013 Pages: 263 - 274

10. Dasatinib: A Guide to Its Use in Chronic Myeloid Leukemia in the EU

    • Gillian M. Keating
    • Katherine A. Lyseng-Williamson
    • Susan J. Keam

    Adis Drug Clinical Q&A 03 April 2013 Pages: 275 - 279